A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Sponsor: NanoString Technologies, Inc.
Collaborators: Cedar Associates LLC|Illumina, Inc.|Grupo Espanol de Investigacion del Cancer de Mama|Spanish Breast Cancer Research Group|Hospital General Universitario Gregorio Marañon|Vall d'Hebron Institute of Oncology